Polycystic kidney disease

Carsten Bergmann, Lisa M. Guay-Woodford, Peter C. Harris, Shigeo Horie, Dorien J.M. Peters, Vicente E. Torres

Research output: Contribution to journalReview articlepeer-review

61 Scopus citations


Cystic kidneys are common causes of end-stage renal disease, both in children and in adults. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are cilia-related disorders and the two main forms of monogenic cystic kidney diseases. ADPKD is a common disease that mostly presents in adults, whereas ARPKD is a rarer and often more severe form of polycystic kidney disease (PKD) that usually presents perinatally or in early childhood. Cell biological and clinical research approaches have expanded our knowledge of the pathogenesis of ADPKD and ARPKD and revealed some mechanistic overlap between them. A reduced ‘dosage’ of PKD proteins is thought to disturb cell homeostasis and converging signalling pathways, such as Ca2+, cAMP, mechanistic target of rapamycin, WNT, vascular endothelial growth factor and Hippo signalling, and could explain the more severe clinical course in some patients with PKD. Genetic diagnosis might benefit families and improve the clinical management of patients, which might be enhanced even further with emerging therapeutic options. However, many important questions about the pathogenesis of PKD remain. In this Primer, we provide an overview of the current knowledge of PKD and its treatment.

Original languageEnglish (US)
Article number50
JournalNature Reviews Disease Primers
Issue number1
StatePublished - Dec 1 2018

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Polycystic kidney disease'. Together they form a unique fingerprint.

Cite this